This week's biggest news for IPF patients is that a computer model found a 7-drug combination that could keep lung function nearly normal — a result researchers have rarely seen before.
FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50–60%.
This is a computer model result — not a prescription. Always talk to your doctor before changing anything.
Researchers are working hard on IPF (a lung disease where scar tissue slowly replaces healthy lung). This week the database grew to over 7,700 studies and nearly 1,900 patient trials worldwide. Most new papers came from Russian and international preprint (early, not yet fully reviewed) sources, meaning science is moving fast — though some findings still need more checking before reaching patients.
The AI tested thousands of drug combinations. The best result used 7 drugs together and kept FVC (the amount of air your lungs can push out — a key measure of lung health) at 98.3%. Normal is 100%, so this is remarkably close to healthy. The drugs targeted scarring, inflammation, and lung cell repair at the same time. These are still computer predictions, not proven in people yet, but they point scientists toward promising real-world trials.
One question to ask your lung doctor at your next visit: 'Are there any new combination drug trials I might qualify for, especially ones targeting lung scarring and inflammation together?'